O'Berry Neuro-Medical Center

Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Wednesday, September 15, 2021 - 4:15pm

QUEST is designed to assess the safety & effectiveness of the Company's AltiusHigh-Frequency Nerve Block system to treat intractable post-amputation pain.

Key Points: 
  • QUEST is designed to assess the safety & effectiveness of the Company's AltiusHigh-Frequency Nerve Block system to treat intractable post-amputation pain.
  • Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids.
  • Neuros Medical, a neuromodulation company, has developed the Altius system for the treatment of chronic post-amputation pain (phantom limb pain and residual limb pain).
  • Post-amputation pain includes both phantom limb and residual limb (or "stump") pain, and impacts nearly one million Americans.

Unity HA Adds Jon J. Snyder as CEO, Announces Name Change to Realeveā„¢

Wednesday, August 18, 2021 - 2:30pm

Unity HA today announced the addition of Jon J. Snyder as Chief Executive Officer.

Key Points: 
  • Unity HA today announced the addition of Jon J. Snyder as Chief Executive Officer.
  • The company also announced the change of their name from Unity HA, to Realeve, to support the commercialization process for their Pulsante SPG Microstimulator System for cluster headache.
  • Unity HA Founder, Dr. Peter Bonutti said, "We are extremely pleased to add a proven, medical device executive with strong neuromodulation and chronic pain therapy development experience in Jon Snyder to lead Realeve going forward."
  • Snyder added, "It is an honor to join the Realeve team and move this impactful therapy closer to the market.